Research programme: HIV infections - SalusAlternative Names: Research programme: antisense HIV infections drug therapies - Salus Therapeutics
Latest Information Update: 11 Sep 2007
At a glance
- Originator Salus Therapeutics
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 13 Nov 2000 Preclinical development for HIV infections treatment in USA (Unknown route)